NCT06131528Completed
Relaxation Breathing Exercises Effects Among Hypertensive Patients
Effects of Relaxation Breathing Exercises on Cardiovascular Parameters Among Hypertensive Patients
Source: ClinicalTrials.gov · Last updated 19 Apr 2024
Brief summary (registry, in English)
The objective of this study will be to compare the effects of Relaxation Breathing Exercises on Cardiovascular Parameters among Hypertensive patients. This study will be a Randomized Clinical trial. Data will be collected from Allied and DHQ hospital Faisalabad. One group will receive Breathing Exercises and other group will receive usual care. All subjects will receive a total of three treatment sessions per week over the period of 12 weeks. Outcome will be measured at baseline, 6th and 12th week of treatment.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 40 (actual)
- First submitted
- 9 Nov 2023
- Start date
- 30 Oct 2023
- Primary completion date
- 30 Jan 2024
- Lead sponsor
- Riphah International University
- Diseases
- High blood pressure
- NCT number
- NCT06131528
What you commit to
- Study type: Interventional
- Participants enrolled: 40
- From 30 Oct 2023 to the primary completion date, 30 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- 3 or more antihypertensive drugs
- Recent major surgery or admission within 1 year
Other illness
- There are signs of secondary hypertension, diabetes mellitus, cardiac disease and pregnancy.
Other
- In use of beta-blockers or centrally acting sympatholytic agents
- Pregnant women
- Blood pressure greater 180/110 mmHg
- Patients with a BMI \>30 kg/ m2
Who the study is looking for
- Age group: Male and female aged 25 - 45 and above without any other uncontrolled cardiovascular or other diseases, with or without antihypertensive medications.
- Patients who have essential hypertension or stage 1 hypertension.
- SBP between 120 and 139 mmHg
- DBP between 80 - 89 mmHg
- An independent lifestyle should be stable on antihypertensive treatment for a minimum of 2 months before the study and no change in medications during participation in the trial.
- Non-smokers
- None was involved in competitive sports activities
Age in the registry: 25 years to 45 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Riphah Rehabilitation Clinic Coordinator of this site? Confirm its status | Lahore | Pakistan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.